Hints and tips:
...David Fredrickson, executive vice-president of oncology business at AstraZeneca, said it was a “massive achievement” in a “really ambitious programme” to be presenting two clinical trials — in lung cancer...
...Dave Fredrickson, executive vice-president of the oncology business unit at AstraZeneca, said if today’s version of the reforms stand, patients with rare conditions, who have benefited from the Orphan Drug...
...Dave Fredrickson, executive vice-president of the company’s oncology business unit, says that if the IRA had been in place in 2014 AstraZeneca may not have filed for approval and launched the drug Lynparza...
...“José really gave us the conviction that this was a medicine that AstraZeneca needed to be a part of,” Fredrickson said....
...“Overnight, the prognosis for these women goes from not having any therapies specifically targeted to her type of cancer, to having a therapy,” Fredrickson said....
International Edition